Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims
MarketWatch
-
- tags:
- article_normal
- Pharmaceuticals
- Healthcare
- Life Sciences
- Consumer Products
- Corporate Strategy
- Planning
- Corporate Crime
- Legal Action
- Regulation
- Government Policy
- New Products
- Services
- Corporate
- Industrial News
- Corporate Organizational Restructuring
- Products
- Cancer
- Political
- General News
- Crime
- Demographic Health
- Health
- Medical Conditions
- Women's Health
- Content Types
- Factiva Filters
- C&E Executive News Filter
- C&E Industry News Filter
- Johnson & Johnson
- JNJ
- corporate strategy
- planning
- corporate crime
- legal action
- regulation
- government policy
- new products
- services
- corporate
- industrial news
- corporate organizational restructuring
- products
- cancer
- political
- general news
- crime
- demographic health
- health
- medical conditions
- women's health
- content types
- factiva filters
- c&e executive news filter
- c&e industry news filter
- pharmaceuticals
- healthcare
- life sciences
- consumer products
- Talc
- Ovarian cancer